×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
My Player placeholder

Become an Oncostream member and receive full access to its content!

You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.

Registration Login


Worldwide schedules comment Share
2891 views

Modérateur : Alexandre de Nonneville

Au programme de cette soirée

18:00 Introduction
 
18:05 Testing HER2, le point de vue de l'anapath
Camille Franchet
 
18:25 HER2-faible, une nouvelle entité dans le cancer du sein ?
Alexandre de Nonneville
 
18:45 Premières lignes des cancers du sein métastatiques HER2-faible
Ophélie Cassuto
 
19:05 Place et séquence des ADC dans les cancers du sein métastatiques HER2-faible
François Bertucci
 
19:25 Débat/discussion - Réponses aux questions
 

 


Webinar #1   Webinar #3

 

Shooting date : 2024-02-01
Last update : 2024-04-03

Suggestions

0
Days
0
Hours
0
Minutes
0
Seconds
Tuesday, November 19th 2024 from 06pm to 07:30pm (GMT+1)
Honolulu : Tuesday, November 19th 2024 from 07am to 08:30am (GMT+1)
San Francisco : Tuesday, November 19th 2024 from 09am to 10:30am (GMT+1)
New York : Tuesday, November 19th 2024 from 12pm to 01:30pm (GMT+1)
Buenos Aires : Tuesday, November 19th 2024 from 02pm to 03:30pm (GMT+1)
London / Dublin : Tuesday, November 19th 2024 from 05pm to 06:30pm (GMT+1)
Paris / Berlin : Tuesday, November 19th 2024 from 06pm to 07:30pm (GMT+1)
Istanbul : Tuesday, November 19th 2024 from 07pm to 08:30pm (GMT+1)
Moscou / Dubaï : Tuesday, November 19th 2024 from 09pm to 10:30pm (GMT+1)
Bangkok : Wednesday, November 20th 2024 from 12am to 01:30am (GMT+1)
Shanghai : Wednesday, November 20th 2024 from 01am to 02:30am (GMT+1)
Tokyo : Wednesday, November 20th 2024 from 02am to 03:30am (GMT+1)
Sydney : Wednesday, November 20th 2024 from 03am to 04:30am (GMT+1)
Wellington : Wednesday, November 20th 2024 from 05am to 06:30am (GMT+1)

Cancer du sein métastatique RH+/HER2- :

individualisation du traitement en 1ère et 2ème ligne

Thursday, October 14th 2021 from 06pm to 07pm (GMT+2)
Honolulu : Thursday, October 14th 2021 from 07am to 08am (GMT+2)
San Francisco : Thursday, October 14th 2021 from 10am to 11am (GMT+2)
New York : Thursday, October 14th 2021 from 01pm to 02pm (GMT+2)
Buenos Aires : Thursday, October 14th 2021 from 02pm to 03pm (GMT+2)
Reykjavik : Thursday, October 14th 2021 from 05pm to 06pm (GMT+2)
London / Dublin : Thursday, October 14th 2021 from 06pm to 07pm (GMT+2)
Paris / Berlin : Thursday, October 14th 2021 from 07pm to 08pm (GMT+2)
Istanbul : Thursday, October 14th 2021 from 08pm to 09pm (GMT+2)
Moscou / Dubaï : Thursday, October 14th 2021 from 09pm to 10pm (GMT+2)
Bangkok : Friday, October 15th 2021 from 12am to 01am (GMT+2)
Shanghai : Friday, October 15th 2021 from 01am to 02am (GMT+2)
Tokyo : Friday, October 15th 2021 from 02am to 03am (GMT+2)
Sydney : Friday, October 15th 2021 from 04am to 05am (GMT+2)
Wellington : Friday, October 15th 2021 from 06am to 07am (GMT+2)

Le cancer du sein métastatique HER2 +, standards actuels et orientations futures

Octobre Rose 2021

Share
Wednesday, April 20th 2022 from 06pm to 07:30pm (GMT+2)
Honolulu : Wednesday, April 20th 2022 from 07am to 08:30am (GMT+2)
San Francisco : Wednesday, April 20th 2022 from 10am to 11:30am (GMT+2)
New York : Wednesday, April 20th 2022 from 01pm to 02:30pm (GMT+2)
Buenos Aires : Wednesday, April 20th 2022 from 02pm to 03:30pm (GMT+2)
Reykjavik : Wednesday, April 20th 2022 from 05pm to 06:30pm (GMT+2)
London / Dublin : Wednesday, April 20th 2022 from 06pm to 07:30pm (GMT+2)
Paris / Berlin : Wednesday, April 20th 2022 from 07pm to 08:30pm (GMT+2)
Istanbul : Wednesday, April 20th 2022 from 08pm to 09:30pm (GMT+2)
Moscou / Dubaï : Wednesday, April 20th 2022 from 09pm to 10:30pm (GMT+2)
Bangkok : Thursday, April 21st 2022 from 12am to 01:30am (GMT+2)
Shanghai : Thursday, April 21st 2022 from 01am to 02:30am (GMT+2)
Tokyo : Thursday, April 21st 2022 from 02am to 03:30am (GMT+2)
Sydney : Thursday, April 21st 2022 from 04am to 05:30am (GMT+2)
Wellington : Thursday, April 21st 2022 from 06am to 07:30am (GMT+2)

Cancer du sein

Cycle de formation en oncologie gynécologique et sénologique de l’Institut Curie

Share
Wednesday, May 10th 2023 from 06pm to 07:30pm (GMT+2)
Honolulu : Wednesday, May 10th 2023 from 07am to 08:30am (GMT+2)
San Francisco : Wednesday, May 10th 2023 from 10am to 11:30am (GMT+2)
New York : Wednesday, May 10th 2023 from 01pm to 02:30pm (GMT+2)
Buenos Aires : Wednesday, May 10th 2023 from 02pm to 03:30pm (GMT+2)
Reykjavik : Wednesday, May 10th 2023 from 05pm to 06:30pm (GMT+2)
London / Dublin : Wednesday, May 10th 2023 from 06pm to 07:30pm (GMT+2)
Paris / Berlin : Wednesday, May 10th 2023 from 07pm to 08:30pm (GMT+2)
Istanbul : Wednesday, May 10th 2023 from 08pm to 09:30pm (GMT+2)
Moscou / Dubaï : Wednesday, May 10th 2023 from 09pm to 10:30pm (GMT+2)
Bangkok : Thursday, May 11th 2023 from 12am to 01:30am (GMT+2)
Shanghai : Thursday, May 11th 2023 from 01am to 02:30am (GMT+2)
Tokyo : Thursday, May 11th 2023 from 02am to 03:30am (GMT+2)
Sydney : Thursday, May 11th 2023 from 04am to 05:30am (GMT+2)
Wellington : Thursday, May 11th 2023 from 06am to 07:30am (GMT+2)

Cancer du sein : actualités et essais en cours, vers où allons-nous ?

Share
Scroll Up